ArticleAIDS and behavior2026
HIV Pre-Exposure Prophylaxis Service Cascade and Risk Factors Associated with Loss to Follow-Up Among Key Populations in Indonesia: Data from a Real-World Pilot Implementation 2021-2023.
Article in AIDS and behavior, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
The pre-exposure prophylaxis (PrEP) care cascade depicting eligibility, initiation, and continuation, as well as loss to follow-up (LTFU) among individuals taking PrEP, has not been systematically evaluated in Indonesia. We examined baseline factors associated with PrEP initiation, the PrEP care cascade, and longitudinal risk factors of LTFU in the Indonesia PrEP Pilot Program, a large-scale implementation program for key populations in Indonesia: men who have sex with men (MSM), female sex workers (FSW), people who inject drugs (PWID), transgender women (TGW), and serodiscordant partners of people living with HIV (SD-PLHIV). Of the 16,469 eligible individuals, 9,124 (55.4%) initiated PrEP (mean age 29.4 [SD 7.5], 85.9% men, 74.4% MSM, 92% from Java-Bali). PrEP initiations were significantly higher among older people, women, FSW and TGW (versus MSM), while markedly lower among PWID and SD-PLHIV and those living in provinces not covered by the program. PrEP continuations at months one and three were very low among FSW (37% and 34%, respectively). The cumulative LTFU rate at 12 months was 41.9% (95% confidence interval [CI], 40.9%-43%). Becoming LTFU was predicted by being younger, being a woman, being an FSW, living in South Sulawesi, West Java, or East Java (versus Jakarta), having no STI diagnoses, reporting consistent condom use, and having high adherence. Our findings revealed gaps in PrEP initiation, continuation, and LTFU among key populations taking PrEP in Indonesia. Targeted interventions are needed to address engagement among those likely to LTFU and populations underserved by the program to improve initiation and continuation.
Indexed as
Identifiers
41231313What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.